Michael Bogenschutz

Scientific Advisor at Journey Colab

Dr. Bogenschutz is a Professor of Psychiatry at NYU Grossman School of Medicine, and Director of the newly established NYU Langone Center for Psychedelic Medicine. He has been conducting clinical research with psychedelics since 2011, including trials of psilocybin-assisted treatment of alcohol use disorder and MDMA-assisted treatment of PTSD. He is also conducting NIH-funded studies on alcohol use disorder and post-traumatic stress disorder.

Timeline

  • Scientific Advisor

    Current role